Enovix (NASDAQ:ENVX) Shares Gap Up – Time to Buy?

Enovix Corporation (NASDAQ:ENVX) gapped up before the market opened on Monday. The stock had previously closed at $2.46, but opened at $2.81. Enovix shares last traded at $2.5640, with a volume of 3,463,392 shares trading hands.

Key Stories Impacting Enovix

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: New 100,000-battery drone order: Enovix received an initial purchase order from a multinational dual-use drone-system provider. Deliveries are scheduled for the first half of 2027 from its military-qualified, TAA-compliant South Korean facility, with potential follow-on orders later in 2027 and beyond. The order supports Enovix’s defense-market growth but has no disclosed dollar value. Enovix Receives 100,000-Battery Drone Order
• Positive Sentiment: Third-quarter revenue exceeded expectations: Preliminary Q3 2026 revenue was approximately $11 million, up 38% year over year and above the company’s $11 million guidance and roughly $9.5 million analyst consensus. The improvement was attributed partly to growing defense demand. Enovix Q3 Preliminary Revenue Rises 38%
• Positive Sentiment: Improved earnings outlook: Enovix guided to third-quarter EPS of approximately negative $0.14, better than the consensus estimate of negative $0.16. The company also raised confidence in its revenue trajectory. Enovix Q3 Revenue Rises 38% to $11 Million
• Neutral Sentiment: Analyst upside remains substantial: The reported average analyst price target is $11.77, well above recent trading levels. Targets are expectations rather than guarantees and depend on Enovix converting its pipeline into repeatable commercial revenue. Enovix Average Target Price
• Negative Sentiment: Profitability remains a concern: Enovix continues to report losses, and its preliminary guidance still implies negative EPS. The stock also remains highly volatile and below its longer-term moving averages, increasing sensitivity to execution, financing, and commercialization risks.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ENVX. Cantor Fitzgerald restated an “overweight” rating and issued a $25.00 price objective on shares of Enovix in a report on Thursday, August 13th. Craig Hallum set a $7.00 price target on shares of Enovix in a research report on Thursday, August 13th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Enovix in a research note on Friday, October 2nd. Canaccord Genuity Group decreased their price objective on shares of Enovix from $15.00 to $10.00 and set a “buy” rating for the company in a research note on Friday, August 14th. Finally, B. Riley Financial dropped their price objective on shares of Enovix from $10.00 to $9.00 and set a “buy” rating for the company in a research report on Thursday, August 13th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, Enovix currently has an average rating of “Moderate Buy” and a consensus target price of $10.77.

Enovix Trading Down 3.1%

The company has a quick ratio of 9.37, a current ratio of 9.71 and a debt-to-equity ratio of 2.46. The firm’s 50 day simple moving average is $3.29 and its two-hundred day simple moving average is $5.07. The stock has a market cap of $550.82 million, a P/E ratio of -3.10 and a beta of 2.49.

Enovix (NASDAQ:ENVX) last issued its earnings results on Wednesday, August 12th. The company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.02. The company had revenue of $9.02 million during the quarter, compared to the consensus estimate of $8.43 million. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%. Enovix’s quarterly revenue was up 20.8% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.13) earnings per share. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. As a group, equities research analysts predict that Enovix Corporation will post -0.80 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of ENVX. Sax Wealth Advisors LLC acquired a new position in Enovix in the 3rd quarter worth about $29,000. Refined Wealth Management raised its stake in shares of Enovix by 0.7% during the 3rd quarter. Refined Wealth Management now owns 850,768 shares of the company’s stock worth $2,467,000 after purchasing an additional 5,918 shares in the last quarter. Apella Capital LLC raised its stake in shares of Enovix by 120.8% during the 3rd quarter. Apella Capital LLC now owns 60,540 shares of the company’s stock worth $176,000 after purchasing an additional 33,120 shares in the last quarter. Sequoia Financial Advisors LLC acquired a new stake in shares of Enovix during the 2nd quarter valued at about $61,000. Finally, Engineers Gate Manager LP lifted its holdings in shares of Enovix by 132.4% during the 2nd quarter. Engineers Gate Manager LP now owns 51,281 shares of the company’s stock valued at $311,000 after buying an additional 29,214 shares during the last quarter. 50.92% of the stock is owned by institutional investors and hedge funds.

Enovix Company Profile

Enovix Corporation is a battery technology company developing lithium-ion batteries that use a silicon-based anode and a three-dimensional cell architecture. The company’s design is intended to increase energy density while incorporating structural features designed to improve safety and cycle life compared with conventional lithium-ion batteries.

Enovix is focused initially on batteries for consumer electronics, including smartphones, wearable devices and other mobile products. It has also identified applications in industrial, medical, aerospace, defense and electric vehicle markets.